These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 14872501)
1. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome. Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501 [TBL] [Abstract][Full Text] [Related]
2. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478 [TBL] [Abstract][Full Text] [Related]
3. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjögren's syndrome. Hulkkonen J; Pertovaara M; Antonen J; Lahdenpohja N; Pasternack A; Hurme M Arthritis Rheum; 2001 Jan; 44(1):176-9. PubMed ID: 11212157 [TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331 [TBL] [Abstract][Full Text] [Related]
5. Primary Sjögren's syndrome: role of the HLA-DRB1*0301-*1501 heterozygotes. Guggenbuhl P; Jean S; Jego P; Grosbois B; Chalès G; Semana G; Lancien G; Veillard E; Pawlotsky Y; Perdriger A J Rheumatol; 1998 May; 25(5):900-5. PubMed ID: 9598888 [TBL] [Abstract][Full Text] [Related]
6. Polymorphism in the 5' regulatory region of the B-lymphocyte activating factor gene is associated with the Ro/La autoantibody response and serum BAFF levels in primary Sjogren's syndrome. Nossent JC; Lester S; Zahra D; Mackay CR; Rischmueller M Rheumatology (Oxford); 2008 Sep; 47(9):1311-6. PubMed ID: 18617551 [TBL] [Abstract][Full Text] [Related]
17. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis. Schneider A; Barmada MM; Slivka A; Martin JA; Whitcomb DC Alcohol; 2004 Jan; 32(1):19-24. PubMed ID: 15066699 [TBL] [Abstract][Full Text] [Related]
18. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273 [TBL] [Abstract][Full Text] [Related]
19. IL-10 promoter -1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjögren's syndrome in a Hungarian cohort. Márka M; Bessenyei B; Zeher M; Semsei I Scand J Immunol; 2005 Nov; 62(5):474-80. PubMed ID: 16305644 [TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha single nucleotide polymorphisms are not independent of HLA class I in UK Caucasians with adult onset idiopathic inflammatory myopathies. Chinoy H; Salway F; John S; Fertig N; Tait BD; Oddis CV; Ollier WE; Cooper RG; Rheumatology (Oxford); 2007 Sep; 46(9):1411-6. PubMed ID: 17586554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]